Zbigniew Król

6.0k total citations
25 papers, 178 citations indexed

About

Zbigniew Król is a scholar working on Infectious Diseases, Molecular Biology and Neurology. According to data from OpenAlex, Zbigniew Król has authored 25 papers receiving a total of 178 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 7 papers in Molecular Biology and 7 papers in Neurology. Recurrent topics in Zbigniew Król's work include COVID-19 Clinical Research Studies (7 papers), SARS-CoV-2 and COVID-19 Research (6 papers) and Long-Term Effects of COVID-19 (5 papers). Zbigniew Król is often cited by papers focused on COVID-19 Clinical Research Studies (7 papers), SARS-CoV-2 and COVID-19 Research (6 papers) and Long-Term Effects of COVID-19 (5 papers). Zbigniew Król collaborates with scholars based in Poland, Germany and United States. Zbigniew Król's co-authors include Robert Gil, Artur Zaczyński, Waldemar Wierzba, Katarzyna Życińska, Piotr Szymański, Mariusz Furmanek, Agnieszka Pawlak, Wojciech Rogowski, Mateusz Soliński and Jan J. Żebrowski and has published in prestigious journals such as PLoS ONE, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Zbigniew Król

24 papers receiving 176 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zbigniew Król Poland 7 90 70 39 27 20 25 178
Sanam Alilou Iran 7 72 0.8× 40 0.6× 34 0.9× 18 0.7× 9 0.5× 12 154
Joanne Michelle D. Gomez United States 7 77 0.9× 59 0.8× 45 1.2× 51 1.9× 14 0.7× 23 234
Yu Nakagama Japan 9 89 1.0× 35 0.5× 16 0.4× 24 0.9× 42 2.1× 41 207
Bruna Gopp Botelho Brazil 4 199 2.2× 113 1.6× 55 1.4× 71 2.6× 14 0.7× 4 291
Christian Prebensen Norway 8 77 0.9× 59 0.8× 15 0.4× 31 1.1× 21 1.1× 12 176
Emanuela Concetta D’Angelo Italy 5 149 1.7× 82 1.2× 32 0.8× 95 3.5× 13 0.7× 13 268
Marcel Martínez‐Cossiani Spain 6 189 2.1× 127 1.8× 39 1.0× 117 4.3× 11 0.6× 13 274
Jésica Abadía‐Otero Spain 7 119 1.3× 93 1.3× 23 0.6× 9 0.3× 28 1.4× 18 210
Muxin Zhu China 6 217 2.4× 142 2.0× 68 1.7× 21 0.8× 12 0.6× 8 261
David Fistera Germany 8 124 1.4× 29 0.4× 13 0.3× 33 1.2× 17 0.8× 19 228

Countries citing papers authored by Zbigniew Król

Since Specialization
Citations

This map shows the geographic impact of Zbigniew Król's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zbigniew Król with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zbigniew Król more than expected).

Fields of papers citing papers by Zbigniew Król

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zbigniew Król. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zbigniew Król. The network helps show where Zbigniew Król may publish in the future.

Co-authorship network of co-authors of Zbigniew Król

This figure shows the co-authorship network connecting the top 25 collaborators of Zbigniew Król. A scholar is included among the top collaborators of Zbigniew Król based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zbigniew Król. Zbigniew Król is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Borowczyk, Martyna, Joanna Szyda, Katarzyna Ziemnicka, et al.. (2024). Genetic predisposition to differentiated thyroid cancer among Polish population. Polskie Archiwum Medycyny Wewnętrznej. 134(3). 1 indexed citations
2.
Pawlak, Agnieszka, Mariusz Furmanek, Piotr Szymański, et al.. (2024). Cardiovascular Magnetic Resonance Imaging in Physically Fit Young Patients Sans Comorbidities Who Recently Recovered from Coronavirus Disease 2019 (COVID-19). Annals of Agricultural and Environmental Medicine. 31(3). 357–361. 1 indexed citations
3.
Mroczek, Magdalena, et al.. (2023). Genetics, Genomics and Emerging Molecular Therapies of Pancreatic Cancer. Cancers. 15(3). 779–779. 9 indexed citations
4.
Szułdrzyński, Konstanty, Mariusz Kowalewski, Miłosz Jankowski, et al.. (2023). Effects of adding the second drainage cannula in severely hypoxemic patients supported with VV ECMO due to COVID‐19‐associated ARDS. Artificial Organs. 47(10). 1622–1631. 1 indexed citations
5.
6.
Król, Zbigniew, et al.. (2023). WGS Data Collections: How Do Genomic Databases Transform Medicine?. International Journal of Molecular Sciences. 24(3). 3031–3031. 5 indexed citations
7.
Szyda, Joanna, Paula Dobosz, Joanna Stojak, et al.. (2023). Better safe than sorry—Whole-genome sequencing indicates that missense variants are significant in susceptibility to COVID-19. PLoS ONE. 18(1). e0279356–e0279356. 7 indexed citations
8.
9.
Kowalewski, Mariusz, Tomasz Pawłowski, Robert Gil, et al.. (2022). Bilateral internal mammary artery in coronary arterybypass grafting using the latest da Vinci Xi robot. Polish Journal of Cardio-Thoracic Surgery. 19(3). 158–160. 1 indexed citations
10.
Soliński, Mateusz, et al.. (2022). Heart rate variability comparison between young males after 4–6 weeks from the end of SARS-CoV-2 infection and controls. Scientific Reports. 12(1). 8832–8832. 22 indexed citations
11.
Pawlak, Agnieszka, et al.. (2022). Ultrastructural Changes in Mitochondria in Patients with Dilated Cardiomyopathy and Parvovirus B19 Detected in Heart Tissue without Myocarditis. Journal of Personalized Medicine. 12(2). 177–177. 4 indexed citations
12.
Rejdak, Konrad, Piotr Fiedor, Robert Bonek, et al.. (2022). The use of amantadine in the prevention of progression and treatment of COVID-19 symptoms in patients infected with the SARS-CoV-2 virus (COV-PREVENT): Study rationale and design. Contemporary Clinical Trials. 116. 106755–106755. 14 indexed citations
13.
Król, Zbigniew, Joanna Szyda, Elżbieta Kaja, et al.. (2022). Gene Variants Related to Cardiovascular and Pulmonary Diseases May Correlate with Severe Outcome of COVID-19. International Journal of Molecular Sciences. 23(15). 8696–8696. 2 indexed citations
14.
Szymański, Piotr, et al.. (2021). Dynamics of humoral response to coronavirus antigens among employees of COVID-dedicated hospital: an observational study. Polskie Archiwum Medycyny Wewnętrznej. 131(7-8). 679–685. 1 indexed citations
15.
Rydzewski, Andrzej, Robert Gil, Andrzej Deptała, et al.. (2021). Convalescent plasma treatment is associated with lower mortality and better outcomes in high-risk COVID-19 patients – propensity-score matched case-control study. International Journal of Infectious Diseases. 105. 209–215. 21 indexed citations
16.
Król, Zbigniew, et al.. (2020). Transformation of a large multi-speciality hospital into a dedicated COVID-19 centre during the coronavirus pandemic. Annals of Agricultural and Environmental Medicine. 27(2). 201–206. 13 indexed citations
17.
Szymański, Piotr, Katarzyna Życińska, Wojciech Rogowski, et al.. (2020). Clinical characteristics and short-term outcomes of coronavirus disease 2019: retrospective, single-center experience of designated hospital in Poland. Polskie Archiwum Medycyny Wewnętrznej. 130(5). 407–411. 47 indexed citations
18.
Król, Zbigniew, et al.. (2002). SURGERY PLANNING TOOLS FOR THE OSSEOUS GRAFTING TREATMENT. Biomedizinische Technik/Biomedical Engineering. 47(s1a). 97–100. 5 indexed citations
19.
Król, Zbigniew, et al.. (1996). [The analysis of plasma beta 2-microglobulin concentration in patients with chronic renal failure treated by hemodialysis].. PubMed. 71(2). 121–5. 1 indexed citations
20.
Zwołińska, Danuta, et al.. (1993). [Concentration of selected trace elements in serum and erythrocytes of children with chronic renal failure and am attempt at deficiency correction with animal blood preparation].. PubMed. 46(3-4). 116–9. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sanam Alilou Breakdown of academic impact, for papers by Joanne Michelle D. Gomez Breakdown of academic impact, for papers by Yu Nakagama Breakdown of academic impact, for papers by Bruna Gopp Botelho Breakdown of academic impact, for papers by Christian Prebensen Breakdown of academic impact, for papers by Emanuela Concetta D’Angelo Breakdown of academic impact, for papers by Marcel Martínez‐Cossiani Breakdown of academic impact, for papers by Jésica Abadía‐Otero Breakdown of academic impact, for papers by Muxin Zhu Breakdown of academic impact, for papers by David Fistera
Rankless by CCL
2026